Health & Social /

High finance: The business of medical marijuana

High finance: The business of medical marijuana

Medical marijuana is predicted to soon become a €55 billion industry in Europe, and a number of Irish businesspeople are leading the charge as they navigate a minefield of regulations across the world

Will Reid manage to go where no HSE boss has gone before?

Will Reid manage to go where no HSE boss has gone before?

Director general Paul Reid’s mission is to end the era of broken budgets, but there is already pushback from within the health service

Settlement of €7m puts spotlight on causes of autism

Settlement of €7m puts spotlight on causes of autism

Last week’s High Court case raised the question of whether birth trauma can cause autism. The evidence is fascinating, but it’s not conclusive

War of words over consent on gene data

War of words over consent on gene data

A Chinese-backed Irish company’s plans to harvest the genetic data of half a million Irish people is threatened by stringent new European rules

Circumventing scientific evidence could have significant implications

Circumventing scientific evidence could have significant implications

On Wednesday last, June 26, the medical cannabis access programme was launched, enabling compassionate access to cannabis for medicinal reasons where conventional treatment has failed

Doctors warn medicinal cannabis access may lead to legalisation

Doctors warn medicinal cannabis access may lead to legalisation

Group calls for clearer guidance from Medical Council on monitoring after launch of pilot programme

State considers the ‘auto-enrolment’ of unconscious patients into medical studies

State considers the ‘auto-enrolment’ of unconscious patients into medical studies

Dr Graham Love, one of Ireland’s leading authorities on health research, has warned that such a move could erode patient trust and stall medical progress

Jury still out on link between birth trauma and autism

Jury still out on link between birth trauma and autism

The €7.25 million out-of-court settlement in the ‘test case’ of a 13-year-old autistic boy meant no legal determination was made on the issue

Health monitor firm backed by Digicel winds up with big loss

Health monitor firm backed by Digicel winds up with big loss

Motech had losses of €3.96 million, according to its last accounts, from 2017, up from €2.33 million in losses the previous year

Surgeon offers to improve HSE’s transgender service

Surgeon offers to improve HSE’s transgender service

Dr Sidhbh Gallagher, who has been living and working in Indiana for the past 12 years, last month attended a new steering committee with the HSE to improve services for people with gender identity issues

State had no choice but to appeal in Morrissey case

State had no choice but to appeal in Morrissey case

The move is an effort to do the right thing and should be commended but instead it is being painted as evidence of a rotten system

Private lab refuses to process smear tests after High Court ruling in Morrissey case

Private lab refuses to process smear tests after High Court ruling in Morrissey case

News that the judgment from Justice Kevin Cross has resulted in changed working practices at laboratories owned by one large global operator will fuel concerns that a new, and problematic, legal precedent has been set

ESRI warns against further health overspend

ESRI warns against further health overspend

The Economic and Social Research Institute said repeated overruns in the annual health budget had a 'clearly negative impact' on the public finances, but added that the issue had been partly masked by surges in corporation tax

No such thing as ‘absolute confidence’ in courts

No such thing as ‘absolute confidence’ in courts

In calling for such an impossible standard of certainty in cervical screening, the judiciary are asking something of doctors that members of the legal profession wouldn’t dream of achieving in the performance of their duties

The Orkambi Buyers Club and the price of hope

The Orkambi Buyers Club and the price of hope

Diarmaid McDonald is challenging the pharma establishment by delivering life-saving drugs to cystic fibrosis sufferers in the North and in Britain